Accueil   Diary - News   All news 3 CLUSTER MEMBER COMPANIES SELECTED BY THE EIC ACCELERATOR, AN EXTRACOMPETITIVE EUROPEAN PROGRAMME

3 CLUSTER MEMBER COMPANIES SELECTED BY THE EIC ACCELERATOR, AN EXTRACOMPETITIVE EUROPEAN PROGRAMME

The European EIC Accelerator scheme aims to support the growth and commercial success of companies developing breakthrough innovations. It finances the roll-out of these innovations from the demonstration phase through to market launch.

 

The EIC Accelerator allows companies to obtain equity financing of up to €15 million, in addition to grant support of up to €2.5 million. France is one of the leading countries in terms of approved projects.

 

The Auvergne-Rhône-Alpes region is the second region in France in terms of winners. In 2020, projects by AXO Science, Signia Therapeutics and Osivax were selected.

 

 

  • AXO Science's THEMIS project aims to develop a disruptive solution for the identification of sex criminals.

 

  • Signia Therapeutics’ SIGNATURA PLATFORM projectconcerns the development of an innovative drug development and repositioning platform for the identification and rapid approval of antimicrobial therapies.

 

  • Osivax’s OSIRIX projectconcerns the development of breakthrough vaccines to prevent pandemics and seasonal epidemics of respiratory viral infections such as multi-seasonal influenza.